MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 115 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $732,963 | +6008.0% | 3,173 | +1734.1% | 0.00% | – |
| Q2 2022 | $12,000 | -29.4% | 173 | +0.6% | 0.00% | – |
| Q1 2022 | $17,000 | +54.5% | 172 | +35.4% | 0.00% | – |
| Q4 2021 | $11,000 | +10.0% | 127 | +2.4% | 0.00% | – |
| Q3 2021 | $10,000 | -23.1% | 124 | -8.1% | 0.00% | – |
| Q2 2021 | $13,000 | +8.3% | 135 | +33.7% | 0.00% | – |
| Q1 2021 | $12,000 | +9.1% | 101 | +4.1% | 0.00% | – |
| Q4 2020 | $11,000 | -94.4% | 97 | -94.1% | 0.00% | -100.0% |
| Q3 2020 | $195,000 | +12.1% | 1,651 | +6.2% | 0.00% | 0.0% |
| Q2 2020 | $174,000 | +85.1% | 1,554 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $94,000 | -29.9% | 1,554 | 0.0% | 0.00% | -60.0% |
| Q3 2019 | $134,000 | -17.8% | 1,554 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $163,000 | +3975.0% | 1,554 | +3690.2% | 0.01% | – |
| Q1 2018 | $4,000 | -55.6% | 41 | -58.2% | 0.00% | -100.0% |
| Q4 2017 | $9,000 | – | 98 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |